Coverart for item
The Resource Health economics from theory to practice : optimally informing joint decisions of research, reimbursement and regulation with health system budget constraints and community objectives, Simon Eckermann

Health economics from theory to practice : optimally informing joint decisions of research, reimbursement and regulation with health system budget constraints and community objectives, Simon Eckermann

Label
Health economics from theory to practice : optimally informing joint decisions of research, reimbursement and regulation with health system budget constraints and community objectives
Title
Health economics from theory to practice
Title remainder
optimally informing joint decisions of research, reimbursement and regulation with health system budget constraints and community objectives
Statement of responsibility
Simon Eckermann
Creator
Author
Subject
Language
eng
Summary
This book provides a robust set of health economic principles and methods to inform societal decisions in relation to research, reimbursement and regulation (pricing and monitoring of performance in practice). We provide a theoretical and practical framework that navigates to avoid common biases and suboptimal outcomes observed in recent and current practice of health economic analysis, as opposed to claiming to be comprehensive in covering all methods. Our aim is to facilitate efficient health system decision making processes in research, reimbursement and regulation, which promote constrained optimisation of community outcomes from a societal perspective given resource constraints, available technology and processes of technology assessment. Importantly, this includes identifying an efficient process to maximize the potential that arises from research and pricing in relation to existing technology under uncertainty, given current evidence and associated opportunity costs of investment. Principles and methods are identified and illustrated across health promotion, prevention and palliative care settings as well as treatment settings. Health policy implications are also highlighted
Member of
Cataloging source
N$T
http://library.link/vocab/creatorName
Eckermann, Simon
Dewey number
338.433621
Index
no index present
LC call number
RA410
Literary form
non fiction
Nature of contents
  • dictionaries
  • bibliography
http://library.link/vocab/subjectName
Medical economics
Label
Health economics from theory to practice : optimally informing joint decisions of research, reimbursement and regulation with health system budget constraints and community objectives, Simon Eckermann
Instantiates
Publication
Copyright
Antecedent source
unknown
Bibliography note
Includes bibliographical references
Carrier category
online resource
Carrier category code
  • cr
Carrier MARC source
rdacarrier
Color
multicolored
Content category
text
Content type code
  • txt
Content type MARC source
rdacontent
Contents
  • Foreword; Text Background and Author Acknowledgement; References; Abbreviations; Contents; Chapter 1: Introduction; 1.1 Overview; 1.2 An Appropriate Underlying Objective Function; 1.3 Principles for Constrained Optimisation Across Health Promotion, Prevention and Care Settings; 1.4 Overview of Chapters; References; Part I: Principles and Practice for Robust Net Benefit Analysis Informing Optimal Reimbursement (Adoption and Financing) Decisions Across Individual and Community-Focused Programs Using Trial, Model and Network Multiplier Methods; References
  • Chapter 2: Principles and Practice for Trial-Based Health Economic Analysis2.1 Overview; 2.2 Principles for Robust Health Technology Assessment; 2.3 Decision Analytic Approaches to Robust Analysis; 2.4 Why Use Incremental Net Benefit and Not Incremental Cost Effectiveness Ratios; 2.5 Illustrating Principles Within Study: The LIPID Trial Case Study; 2.6 Representing Cost Effectiveness Uncertainty; 2.7 Bootstrapping the CE Distribution; 2.8 Fieller's Method; 2.9 Useful Cost Effectiveness Summary Measures from Bivariate Distributions Conditioning on Threshold Values for Effect
  • 2.10 How Should Economically Meaningful Threshold Values for Effects Be Estimated?2.11 Conclusion; 2.12 Discussion - Satisfying Coverage, the Need for Robust Evidence Synthesis, Translation and Extrapolation; References; Chapter 3: Avoiding Frankenstein's Monster and Partial Analysis Problems: Robustly Synthesising, Translating and Extrapolating Evidence; 3.1 Introduction; 3.2 Setting the Scene: Frankenstein's Monster or the Vampire of Trials; 3.3 Cost Minimisation and the Absence of Evidence Fallacies
  • 3.4 Indirect Comparison and Avoiding Framing Biases with Relative Risk in Evidence Synthesis of Binary Outcomes3.4.1 What Causes Reversal of Treatment Effect with Relative Risk?; 3.5 Preventing Framing Biases in Evidence Translation; 3.5.1 Does Relative Risk Consistently Estimate Absolute Risk Difference in Translating Evidence with Alternate Framing of Binary Events?; 3.5.2 Does the Odds Ratio Allow Consistent Estimation of Absolute Risk Difference in Translating Trial Evidence to Jurisdictions of Interest?
  • 3.6 Extrapolating Cost Effectiveness Evidence Beyond Trial Duration for a Jurisdiction of InterestReferences; Chapter 4: Beyond the Individual: Evaluating Community-Based Health Promotion and Prevention Strategies and Palliative Care Domains of Effect; 4.1 Introduction; 4.2 Evaluating Health Promotion and Prevention: Moving Beyond Individual Measures Within Study; 4.2.1 The Stephanie Alexander Evaluation Case Study; 4.2.2 Conclusion: Health Promotion and Prevention in Complex Community Settings; 4.3 Palliative Care; 4.3.1 Economic Evaluation in Palliative Care; References
Dimensions
unknown
Extent
1 online resource.
File format
unknown
Form of item
online
Isbn
9783319506111
Level of compression
unknown
Media category
computer
Media MARC source
rdamedia
Media type code
  • c
Quality assurance targets
not applicable
Reformatting quality
unknown
Sound
unknown sound
Specific material designation
remote
System control number
ocn978273851
Label
Health economics from theory to practice : optimally informing joint decisions of research, reimbursement and regulation with health system budget constraints and community objectives, Simon Eckermann
Publication
Copyright
Antecedent source
unknown
Bibliography note
Includes bibliographical references
Carrier category
online resource
Carrier category code
  • cr
Carrier MARC source
rdacarrier
Color
multicolored
Content category
text
Content type code
  • txt
Content type MARC source
rdacontent
Contents
  • Foreword; Text Background and Author Acknowledgement; References; Abbreviations; Contents; Chapter 1: Introduction; 1.1 Overview; 1.2 An Appropriate Underlying Objective Function; 1.3 Principles for Constrained Optimisation Across Health Promotion, Prevention and Care Settings; 1.4 Overview of Chapters; References; Part I: Principles and Practice for Robust Net Benefit Analysis Informing Optimal Reimbursement (Adoption and Financing) Decisions Across Individual and Community-Focused Programs Using Trial, Model and Network Multiplier Methods; References
  • Chapter 2: Principles and Practice for Trial-Based Health Economic Analysis2.1 Overview; 2.2 Principles for Robust Health Technology Assessment; 2.3 Decision Analytic Approaches to Robust Analysis; 2.4 Why Use Incremental Net Benefit and Not Incremental Cost Effectiveness Ratios; 2.5 Illustrating Principles Within Study: The LIPID Trial Case Study; 2.6 Representing Cost Effectiveness Uncertainty; 2.7 Bootstrapping the CE Distribution; 2.8 Fieller's Method; 2.9 Useful Cost Effectiveness Summary Measures from Bivariate Distributions Conditioning on Threshold Values for Effect
  • 2.10 How Should Economically Meaningful Threshold Values for Effects Be Estimated?2.11 Conclusion; 2.12 Discussion - Satisfying Coverage, the Need for Robust Evidence Synthesis, Translation and Extrapolation; References; Chapter 3: Avoiding Frankenstein's Monster and Partial Analysis Problems: Robustly Synthesising, Translating and Extrapolating Evidence; 3.1 Introduction; 3.2 Setting the Scene: Frankenstein's Monster or the Vampire of Trials; 3.3 Cost Minimisation and the Absence of Evidence Fallacies
  • 3.4 Indirect Comparison and Avoiding Framing Biases with Relative Risk in Evidence Synthesis of Binary Outcomes3.4.1 What Causes Reversal of Treatment Effect with Relative Risk?; 3.5 Preventing Framing Biases in Evidence Translation; 3.5.1 Does Relative Risk Consistently Estimate Absolute Risk Difference in Translating Evidence with Alternate Framing of Binary Events?; 3.5.2 Does the Odds Ratio Allow Consistent Estimation of Absolute Risk Difference in Translating Trial Evidence to Jurisdictions of Interest?
  • 3.6 Extrapolating Cost Effectiveness Evidence Beyond Trial Duration for a Jurisdiction of InterestReferences; Chapter 4: Beyond the Individual: Evaluating Community-Based Health Promotion and Prevention Strategies and Palliative Care Domains of Effect; 4.1 Introduction; 4.2 Evaluating Health Promotion and Prevention: Moving Beyond Individual Measures Within Study; 4.2.1 The Stephanie Alexander Evaluation Case Study; 4.2.2 Conclusion: Health Promotion and Prevention in Complex Community Settings; 4.3 Palliative Care; 4.3.1 Economic Evaluation in Palliative Care; References
Dimensions
unknown
Extent
1 online resource.
File format
unknown
Form of item
online
Isbn
9783319506111
Level of compression
unknown
Media category
computer
Media MARC source
rdamedia
Media type code
  • c
Quality assurance targets
not applicable
Reformatting quality
unknown
Sound
unknown sound
Specific material designation
remote
System control number
ocn978273851

Library Locations

Processing Feedback ...